Cargando…
Serotonin signals through a gut-liver axis to regulate hepatic steatosis
Nonalcoholic fatty liver disease (NAFLD) is increasing in worldwide prevalence, closely tracking the obesity epidemic, but specific pharmaceutical treatments for NAFLD are lacking. Defining the key molecular pathways underlying the pathogenesis of NAFLD is essential for developing new drugs. Here we...
Autores principales: | Choi, Wonsuk, Namkung, Jun, Hwang, Inseon, Kim, Hyeongseok, Lim, Ajin, Park, Hye Jung, Lee, Hye Won, Han, Kwang-Hyub, Park, Seongyeol, Jeong, Ji-Seon, Bang, Geul, Kim, Young Hwan, Yadav, Vijay K., Karsenty, Gerard, Ju, Young Seok, Choi, Chan, Suh, Jae Myoung, Park, Jun Yong, Park, Sangkyu, Kim, Hail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240035/ https://www.ncbi.nlm.nih.gov/pubmed/30446669 http://dx.doi.org/10.1038/s41467-018-07287-7 |
Ejemplares similares
-
Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Choi, Wonsuk, et al.
Publicado: (2019) -
Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance
por: Namkung, Jun, et al.
Publicado: (2018) -
Peripheral Serotonin: a New Player in Systemic Energy Homeostasis
por: Namkung, Jun, et al.
Publicado: (2015) -
Serotonin Regulates De Novo Lipogenesis in Adipose Tissues through Serotonin Receptor 2A
por: Shong, Ko Eun, et al.
Publicado: (2020) -
Erratum: Correction of Figure. Serotonin Regulates De Novo Lipogenesis in Adipose Tissues through Serotonin Receptor 2A
por: Shong, Ko Eun, et al.
Publicado: (2020)